Related Experiment Video

Updated: Jun 27, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.3K

Single-Pill Combination Therapy for the Management of Hypertension: A Scientific Statement From the American Heart

Jordan B King, Jaejin An, Brandon K Bellows

    Hypertension (Dallas, Tex. : 1979)
    |December 15, 2025
    PubMed

    Insights

    Single-pill combination medications for hypertension offer improved blood pressure control and patient adherence compared to traditional stepped care. These combinations simplify treatment, reduce pill burden, and enhance cardiovascular outcomes.

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Hypertension poses a significant global health challenge with suboptimal blood pressure control.
    • Cardiovascular diseases are a major risk associated with uncontrolled hypertension.

    Purpose of the Study:

    • To review the clinical evidence for single-pill combination medications in hypertension management.
    • To outline strategies for implementing these combination therapies in clinical practice.
    • To identify areas for future research in hypertension pharmacotherapy.

    Main Methods:

    • Review of existing clinical evidence on single-pill combination medications.
    • Analysis of comparative effectiveness against stepped care approaches.
    • Evaluation of implementation strategies and potential limitations.

    Main Results:

    • Single-pill combinations achieve faster and more sustained blood pressure control than stepped care.
    • These medications simplify regimens, improve adherence, and reduce pill burden.
    • Potential benefits include cost-effectiveness and reduced adverse effects due to complementary actions.

    Conclusions:

    • Single-pill combination medications represent a valuable strategy for improving hypertension management and patient outcomes.
    • Wider adoption in routine practice can lead to better long-term cardiovascular health.
    • Addressing dosing flexibility and availability of specific combinations are key considerations.

    Keywords:
    AHA Scientific Statementsantihypertensive agentscardiovascular diseasescost-effectiveness analysisdrug combinationshypertensionmedication adherence

    More Related Videos

    Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

    Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

    Published on: August 16, 2021

    4.0K
    Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients03:47

    Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

    Published on: July 12, 2024

    1.1K

    Related Concept Videos

    Hypertension and Regulation of Blood Pressure01:18

    Hypertension and Regulation of Blood Pressure

    Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

    The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
    Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

    Hypertension IV: Drug Therapy and Lifestyle Modifications

    Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
    Hypertension V: Nursing Management01:23

    Hypertension V: Nursing Management

    The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...